Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Humoral and Cell-Mediated Immune Responses Following a Booster Dose of Pertussis Vaccine

NCT03147898 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT03147898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03147898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Humoral and Cell-Mediated Immune Responses Following a Booster Dose of Pertussis Vaccine
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
April 12, 2017
Completion date
July 9, 2018
Enrollment
90 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pertussis, whooping cough